Myelodysplastic syndrome medical therapy
Myelodysplastic syndrome Microchapters
Myelodysplastic syndrome medical therapy On the Web
American Roentgen Ray Society Images of Myelodysplastic syndrome medical therapy
- Treatment is based on the type of myelodysplastic syndrome and the person's age and general health. The goal of treatment for myelodysplastic syndrome is to:
- Relieve symptoms
- Slow or prevent progression of the disease
- Improve quality of life
- The most common chemotherapy drug used to treat myelodysplastic syndrome is cytarabine. Cytarabine may be combined with other pharmacological agents such as:
- Other chemotherapeutic agents that may be used to treat myelodysplastic syndrome include:
- Supportive therapy is given to relieve symptoms and lessen the problems caused by abnormal blood cell counts or treatment for myelodysplastic syndrome.
- Patients with anemia may receive blood transfusions to correct the red blood cell counts.
- Frequent blood transfusions can be complicated by a buildup of extra iron in the body, which is treated with drug therapy.
- Patients with bleeding problems due to low platelet counts may be given platelet transfusions.
- Epoetin (erythropoietin)
- Helps improve production of red blood cells
- Also called granulocyte colony-stimulating factor (G-CSF)
- Helps improve production of white blood cells
- A long-acting G-CSF
- treats excess iron in the blood
- sometimes given with Vitamin C.
- decreases the need for transfusions in people with a specific chromosome change
- decreases the need for transfusions in certain types of myelodysplastic syndrome
- help to prevent or treat infections
- stop cancer cells from producing DNA or RNA so the cells die
- Treatment of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 15, 2015